Vivos Therapeutics, Inc. (NASDAQ:VVOS) ("Vivos" or the "Company") today announced that it has received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock
Vivos Therapeutics, Inc. (NASDAQ:VVOS) is pleased to announce that it has received multiple Class I clearances by the Therapeutic Goods Administration (TGA) of Australia, a Tier 1 regulatory body for multiple
Vivos Therapeutics, Inc. (NASDAQ:VVOS) ("Vivos" or "the Company"), a revenue-stage medical technology company focused on developing innovative treatments for patients suffering from
Gainers
RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.
Gainers
Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for experimental narcolepsy drug.